Jhunjhunwala and his better half Rekha Jhunjhunwala owned a 5.05 per cent stake in Titan as of March 31, 2022. The June quarter shareholdin...

According to a regulatory filing by the company, the seasoned investor and his better half jointly held a 7.5 per cent stake in the company...

The pharmaceutical player's net loss narrowed to Rs 44.62 crore in the March 2022 quarter. The company reported a net loss of Rs 135.02 cro...

Rakesh Jhunjhunwala has sold some or all of his stake in Steel Authority of India (SAIL), the latest shareholding data released by the comp...

"Business saw subdued activity in top cities due to Omicron wave in January, a very strong resurgence in February and again a drop in custo...

"History shows that ultimately earnings are slaves of cash flow valuations. Anybody may go up for a temporary period but it is not going to...

A host of brokerages are expecting the automaker to report a loss for the quarter. They noted that chip shortage continued to dent volumes ...

An updated shareholding pattern by the PSU bank post-QIP suggests Rakesh Jhunjhunwala has entered the stock with a 1.59 per cent stake.

The stake sale by Eastspring India comes as the lock-in period for anchor investors, who participated in the company’s initial public offer...

Jhunjhunwala’s wife Rekha Jhunjhunwala sold 50,000 shares of Titan during the quarter, according to a latest regulatory filing.

Rekha Rakesh Jhunjhunwala held 96,90,575 shares, or 1.09 per cent stake in the company as of September 30 against 97,40,575 shares or 1.10 ...

Shares of Titan traded 1.06 per cent down at Rs 957 in Wednesday’s early trade.

According to merchant banking sources, the initial share-sale is expected to fetch Rs 350 crore.

The Sensex posted triple-digit loss to end at 28,668, down 0.36 per cent. The Nifty50 could not anchor the 8,850 level well, settling the w...

Ace investor says the domestic equity market is nearing its bottom and a strong upturn is around the corner. India will be top among EMs, h...

Rakesh Jhunjhunwala says he is positive on pharma, which he calls a big player, and housing finance companies, but remains cautious on bank...

SKS Capital has expressed its inability to purchase the warrants and accordingly both the parties agreed to terminate the agreement.